-+ 0.00%
-+ 0.00%
-+ 0.00%

GeneDx Names Everett Cunningham CEO, Succeeding Katherine Stueland

PUBT·11/18/2026 13:04:12
GeneDx Names Everett Cunningham CEO, Succeeding Katherine Stueland
  • GeneDx appointed Everett Cunningham CEO and board member, effective on or before December 15, 2026.
  • Katherine Stueland will leave both roles when Cunningham joins, remaining an adviser through January 31, 2027.
  • Cunningham most recently served as Quanterix president and CEO. He brings more than 35 years of experience across diagnostics and other healthcare businesses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261118748368) on November 18, 2026, and is solely responsible for the information contained therein.